| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | BLUEPRINT MEDICINES CORP COM | 2,278,459 | 60,015,000 | 10.23% | ||
| 2 | CHEMOCENTRYX INC | 6,677,722 | 54,090,000 | 9.22% | ||
| 3 | CTI BIOPHARMA CORP | 43,795,613 | 53,869,000 | 9.18% | ||
| 4 | CONCERT PHARMACEUTICALS INC COM | 2,232,014 | 42,341,000 | 7.22% | ||
| 5 | ONCOTHYREON INC COM N/C EFF 6/ | 18,799,368 | 41,735,000 | 7.11% | ||
| 6 | VITAE PHARMACEUTICALS INC | 2,061,325 | 37,310,000 | 6.36% | ||
| 7 | IRONWOOD PHARMACEUTICALS INC COM CL A | 2,935,975 | 34,028,000 | 5.80% | ||
| 8 | CYTOKINETICS INC | 2,920,628 | 30,550,000 | 5.21% | ||
| 9 | ARRAY BIOPHARMA INC COM | 6,682,711 | 28,201,000 | 4.81% | ||
| 10 | FORWARD PHARMA A/S | 1,441,287 | 27,384,000 | 4.67% | ||
| 11 | ONCOMED PHARMACEUTICALS INC | 991,433 | 22,347,000 | 3.81% | ||
| 12 | Exelexis | 18,842,778 | 22,187,000 | 3.78% | PRN | |
| 13 | LOXO ONCOLOGY INC COM | 711,067 | 20,230,000 | 3.45% | ||
| 14 | ArQule Inc | 6,809,843 | 14,777,000 | 2.52% | ||
| 15 | QLT INC | 5,364,385 | 14,269,000 | 2.43% | ||
| 16 | CYTOMX THERAPEUTICS INC COM | 608,848 | 12,707,000 | 2.17% | ||
| 17 | TOBIRA THERAPEUTICS INC | 1,253,401 | 12,597,000 | 2.15% | ||
| 18 | FIVE PRIME THERAPEUTICS INC | 300,000 | 12,450,000 | 2.12% | ||
| 19 | Nivalis Therapeutics Inc | 1,195,013 | 9,249,000 | 1.58% | ||
| 20 | XENON PHARMACEUTICALS INC | 1,125,572 | 9,050,000 | 1.54% | ||
| 21 | GTX INC | 11,163,136 | 7,814,000 | 1.33% | ||
| 22 | Sunesis Pharmaceuticals I | 4,777,381 | 4,288,000 | 0.73% | ||
| 23 | PAIN THERAPEUTICS INC | 1,852,353 | 3,242,000 | 0.55% | ||
| 24 | Catalyst Biosciences | 970,948 | 3,039,000 | 0.52% | ||
| 25 | GLOBEIMMUNE INC | 657,653 | 2,539,000 | 0.43% | ||
| 26 | ARRAY BIOPHARMA INC 3 06/01/2020 | 2,500,000 | 2,327,000 | 0.40% | PRN | |
| 27 | MAST THERAPEUTICS | 3,696,961 | 1,554,000 | 0.26% | ||
| 28 | CALITHERA BIOSCIENCES INC | 167,900 | 1,286,000 | 0.22% | ||
| 29 | BIOTA PHARMACEUTIALS INC COM | 350,776 | 681,000 | 0.12% | ||
| 30 | Nephrogenex Inc | 392,156 | 627,000 | 0.11% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000921895-16-003386, filed 2016.02.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
